Journal of Enzyme Inhibition and Medicinal Chemistry | |
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)? | |
Davide Bassani1  Matteo Pavan1  Mattia Sturlese1  Stefano Moro1  | |
[1] Molecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences University of Padova, Padova, Italy; | |
关键词: SARS-CoV-2; bat coronavirus; sarbecovirus; BANAL; Laos; MPro; | |
DOI : 10.1080/14756366.2022.2062336 | |
来源: DOAJ |
【 摘 要 】
Despite a huge effort by the scientific community to determine the animal reservoir of SARS-CoV-2, which led to the identification of several SARS-CoV-2-related viruses both in bats and in pangolins, the origin of SARS-CoV-2 is still not clear. Recently, Temmam et al. reported the discovery of bat coronaviruses with a high degree of genome similarity with SARS-CoV-2, especially concerning the RBDs of the S protein, which mediates the capability of such viruses to enter and therefore infect human cells through a hACE2-dependent pathway. These viruses, especially the one named BANAL-236, showed a higher affinity for the hACE2 compared to the original strain of SARS-CoV-2. In the present work, we analyse the similarities and differences between the 3CL protease (main protease, Mpro) of these newly reported viruses and SARS-CoV-2, discussing their relevance relative to the efficacy of existing therapeutic approaches against COVID-19, particularly concerning the recently approved orally available Paxlovid, and the development of future ones.
【 授权许可】
Unknown